IPO registrations (S-1, F-1) · Registrants
BAXANO SURGICAL, INC.
- SEC CIK
- 1230355 · filings on EDGAR ↗
- Name on the registration
- TRANS1 INC
- Former names
- TRANS1 INC (2003–2013)
- Registration
- Form S-1, first filed 2007-07-24, last 2007-10-12; 1 initial registration, 4 amendments
- Outcome
- Final prospectus filed 2007-10-17; declared effective 2007-10-16
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 110 HORIZON DRIVE, SUITE 230, Raleigh, NC 27615
- EDGAR entity type
- operating
- Insiders and CEO pay
- BAXANO SURGICAL, INC. on the corporate pages
Offering terms
- Proposed price range
- $12.00–$14.00 per share (S-1/A filed 2007-10-12)
- Final price
- $15.00 per share, above the range (424B4 filed 2007-10-17, an initial public offering)
- Shares sold
- 5,500,000
- Gross proceeds
- $82,500,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol TSON
- Lead underwriters
- Lehman Brothers; Piper Sandler
- Syndicate
- Cowen; Wachovia
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Baxano Surgical, Inc. Fuzzy (name and state)
- Business registration: Baxano Surgical, Inc. Fuzzy (name and state)
- Business registration: BAXANO SURGICAL, INC. Fuzzy (name and state)
- Business registration: BAXANO SURGICAL, INC. Fuzzy (name and state)
- Federal award recipient: BAXANO SURGICAL, INC. Fuzzy (name and state)
- Form D issuer: BAXANO SURGICAL, INC. EXACT (CIK (EXACT))
- SEC filer: BAXANO SURGICAL, INC. EXACT (CIK (EXACT))
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2007-07-24 | S-1 | S-1 (registration) | TRANS1 INC | 0000950144-07-006784 ↗ |
| 2007-09-04 | S-1/A | S-1/A (amendment) | TRANS1 INC | 0000950134-07-019456 ↗ |
| 2007-09-28 | S-1/A | S-1/A (amendment) | TRANS1 INC | 0000892569-07-001216 ↗ |
| 2007-10-09 | S-1/A | S-1/A (amendment) | TRANS1 INC | 0000950134-07-021018 ↗ |
| 2007-10-12 | S-1/A | S-1/A (amendment) | TRANS1 INC | 0000892569-07-001295 ↗ |
| 2007-10-16 | EFFECT | EFFECT (declared effective) | TRANS1 INC | 9999999995-07-004062 ↗ |
| 2007-10-17 | S-1MEF | S-1MEF (added securities) | TRANS1 INC | 0000950134-07-021454 ↗ |
| 2007-10-17 | 424B4 | 424B4 (final prospectus) | TRANS1 INC | 0000950137-07-015647 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2007-10-12 | S-1/A | registration statement | $12.00–$14.00 | 5,500,000 | - | Nasdaq TSON | 4 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4 | document ↗ | |
| 2007-10-17 | 424B4 | final prospectus | $15.00 | 5,500,000 | $82,500,000 | Nasdaq TSON | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Advanced Technology Ventures VII(B), L.P. | TenPercentOwner | 4 | 2007–2011 | ||
| Advanced Technology Ventures VII(C), L.P. | TenPercentOwner | 4 | 2007–2011 | ||
| ADVANCED TECHNOLOGY VENTURES VII LP | TenPercentOwner | 4 | 2007–2011 | ||
| Assell Robert L. | Officer | VP, Product Development | 2 | 2007 | |
| ATV Associates VII, L.L.C. | TenPercentOwner | 4 | 2007–2011 | ||
| ATV Entrepreneurs VII, L.P. | TenPercentOwner | 4 | 2007–2011 | ||
| Carusi Michael A | Director | 9 | 2007–2012 | ||
| CUTLASS CAPITAL AFFILIATES FUND LP | TenPercentOwner | 2 | 2007 | ||
| CUTLASS CAPITAL LP | TenPercentOwner | 2 | 2007 | ||
| Cutlass Capital Management, L.L.C. | TenPercentOwner | 2 | 2007 | ||
| Cutlass Capital Principals Fund, L.L.C. | TenPercentOwner | 2 | 2007 | ||
| DANN MITCHELL | Director | 12 | 2007–2011 | ||
| DELPHI BIOINVESTMENTS VI LP | TenPercentOwner | 10 | 2007–2011 | ||
| DELPHI MANAGEMENT PARTNERS VI LLC | TenPercentOwner | 10 | 2007–2011 | ||
| DELPHI VENTURES VI LP | TenPercentOwner | 10 | 2007–2011 | ||
| Hetz Edwin David | TenPercentOwner | 1 | 2007 | ||
| Jackson William F. | Officer | VP Regulatory Clinical Quality | 1 | 2007 | |
| Luetkemeyer Michael L. | Officer | Chief Financial Officer | 2 | 2007–2008 | |
| Martin Robert S. | Officer | VP, International Sales | 3 | 2007–2011 | |
| Osgood Jonathan W. | Director | 8 | 2007–2012 | ||
| RANDALL RICHARD D | Director; Director,Officer | CEO; Chairman of the Board; Executive Chairman; President, CEO | 9 | 2007–2012 | |
| SAPIENT CAPITAL LP | TenPercentOwner | 2 | 2007 | ||
| Sapient Capital Management, L.L.C. | TenPercentOwner | 2 | 2007 | ||
| Sapient Capital Management, L.P. | TenPercentOwner | 2 | 2007 | ||
| SHAPIRO JAMES M | Director | 13 | 2007–2014 | ||
| SIMMONS RICARDO J | Officer | VP, Marketing and Sales | 4 | 2007–2008 | |
| SLATTERY JOSEPH P | Director; Officer | Executive V.P. and CFO; Executive VP and CFO | 21 | 2007–2013 | |
| ATV Alliance 2002, L.P. | TenPercentOwner | 2 | 2008–2011 | ||
| ATV Alliance Associates, L.L.C. | TenPercentOwner | 2 | 2008–2011 | ||
| LAVIOLETTE PAUL A | Director | 9 | 2008–2014 | ||
| BOCHNOWSKI JAMES J | TenPercentOwner | 7 | 2009 | ||
| Delphi BioInvestments VIII LP | TenPercentOwner | 8 | 2009–2011 | ||
| Delphi Management Partners VIII, L.L.C. | TenPercentOwner | 8 | 2009–2011 | ||
| DELPHI VENTURES VIII LP | TenPercentOwner | 8 | 2009–2011 | ||
| DOUGLASS DAVID L | TenPercentOwner | 7 | 2009 | ||
| MARONEY JOHN F | TenPercentOwner | 7 | 2009 | ||
| PAKIANATHAN DEEPIKA | TenPercentOwner | 7 | 2009 | ||
| ROEDER DOUGLAS A | TenPercentOwner | 7 | 2009 | ||
| Reali Kenneth Michael | Director,Officer; Officer | President and CEO; President & CEO; President & COO | 11 | 2010–2014 | |
| Montgomery Bobby Dwayne | Officer | Vice President, Sales; VP, Sales | 5 | 2010–2013 | |
| SIMPSON DAVID J | Director | 19 | 2010–2014 | ||
| Feiler Frederic Charles JR | Officer | Vice President of Marketing; VP of Marketing | 6 | 2010–2014 | |
| Ainsworth Stephen D | Officer | VP of Research and Development | 6 | 2010–2014 | |
| Ramchandani Mukesh | Officer | VP Business Development; VP, Business Development | 5 | 2010–2014 | |
| Fischgrund Jeffrey | Director | 5 | 2012–2014 | ||
| Fitts Stephanie M | Officer | VP - Regulatory, Qlty & Compl; VP-Regulatory, Qlty & Control | 4 | 2012–2014 | |
| Stautberg Mark | Director | 5 | 2013–2014 | ||
| HIRSCH RUSSELL C | Director; Director,TenPercentOwner | 3 | 2013–2014 | ||
| Welsh Greg | Officer | Vice President of Operations; VICE PRESIDENT OF OPERATIONS | 3 | 2013–2014 | |
| Young Roderick A | Director | 3 | 2013–2014 | ||
| Prospect Management Co. III, L.L.C. | TenPercentOwner | 1 | 2013 | ||
| Prospect Venture Partners III L P | TenPercentOwner | 1 | 2013 | ||
| SCHNELL DAVID | TenPercentOwner | 1 | 2013 | ||
| Shannon Timothy M | Officer | Interim CFO | 2 | 2013–2014 | |
| Slusser Greg D | Officer | VP of Commercial Operations | 3 | 2013–2014 | |
| Pickens Matthew | Officer | Please see remarks | 1 | 2014 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2014-03-26 | BAXANO SURGICAL, INC. | Other Health Care | $9,993,680 | $9,993,680 | 5 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Baxano Surgical, Inc. | NC | State business registries | name and state |
| Business registration | Baxano Surgical, Inc. | NC | State business registries | name and state |
| Business registration | BAXANO SURGICAL, INC. | NC | State business registries | name and state |
| Business registration | BAXANO SURGICAL, INC. | NC | State business registries | name and state |
| Plan sponsor | BAXANO SURGICAL | NC | Form 5500 (employee benefit plans) | name and state |
| Federal award recipient | BAXANO SURGICAL, INC. | NC | Federal spending (USAspending) | name and state |
| Form D issuer | BAXANO SURGICAL, INC. | NC | Form D private offerings | CIK (EXACT) |
| Patent assignee | Baxano Surgical, Inc. | NC | Patents (USPTO) | name and state |
| SEC filer | BAXANO SURGICAL, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | BAXANO SURGICAL, INC. | NC | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, NC first:
- CLOSURE MEDICAL CORP NC
- Liquidia Technologies Inc NC
- MedPro Safety Products, Inc. NC
- Bioventus Inc. NC
- ASENSUS SURGICAL, INC. NC
- MIV THERAPEUTICS INC A1
- BIOCUREX INC A1
- Enox Biopharma Inc A1
- Stimcell Energetics Inc. A1
- EVOME MEDICAL TECHNOLOGIES INC. A1
In other datasets, the same topic (Technology) in NC:
- Form D issuer: 1336 Studios, LLC (Form D private offerings)
- Lobbying client: ACN INC (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology